AxSpA can bring on plantar fasciitis, which is when inflammation in the heel causes the sole of your foot to hurt. You may ...

Alcohol consumption was associated with lower levels of axSpA disease activity and spinal pain, but may be linked to ...

TNF inhibitors offered greater protection against fractures than NSAIDs in patients with axial spondyloarthritis (axSpA).

Acelyrin (NASDAQ:SLRN – Get Free Report) had its target price lowered by analysts at HC Wainwright from $8.00 to $6.00 in a ...

Study finds TNF inhibitors lower hip and spine fracture risk in axial spondyloarthritis, addressing inflammation-related ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The chronic back pain of axial spondyloarthritis (axSpA) may be accompanied after diagnosis by three primary extra ...

High-dose nonsteroidal anti-inflammatory drug use among patients with axial spondyloarthritis (axSpA) may not increase the risk of developing hypertension, according to study results presented at the ...

The following is a summary of “Association of Therapies for Axial Spondyloarthritis on the Risk of Hip and Spine Fractures,” published in the December 2024 issue of Rheumatology by Driscoll et al.

MRT-6160 is under clinical development by Monte Rosa Therapeutics and currently in Phase I for Multiple Sclerosis.

Calculating the probability of a diagnosis of axial spondyloarthritis using the LR product approach. Calculating the probability of a diagnosis of axial spondyloarthritis using a diagnostic algorithm.

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...